Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.


Journal

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
ISSN: 1815-7920
Titre abrégé: Int J Tuberc Lung Dis
Pays: France
ID NLM: 9706389

Informations de publication

Date de publication:
01 04 2019
Historique:
entrez: 9 5 2019
pubmed: 9 5 2019
medline: 6 2 2020
Statut: ppublish

Résumé

<sec id="st1"> <title>BACKGROUND</title> The association between respiratory impairment and tuberculosis (TB) treatment outcomes is not clear. </sec> <sec id="st2"> <title>METHODS</title> We prospectively evaluated respiratory health status, measured using the Saint George's Respiratory Questionnaire (SGRQ), in a cohort of new adult pulmonary TB cases during and up to 18 months following treatment in India. Associations between total SGRQ scores and poor treatment outcomes of failure, recurrence and all-cause death were measured using multivariable Poisson regression. </sec> <sec id="st3"> <title>RESULTS</title> We enrolled 455 participants contributing 619 person-years at risk; 39 failed treatment, 23 had recurrence and 16 died. The median age was 38 years (interquartile range 26-49); 147 (32%) ever smoked. SGRQ scores at treatment initiation were predictive of death during treatment (14% higher risk per 4-point increase in baseline SGRQ scores, 95%CI 2-28,

Identifiants

pubmed: 31064624
doi: 10.5588/ijtld.18.0551
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

450-457

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI097494
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069465
Pays : United States
Organisme : FIC NIH HHS
ID : D43 TW009340
Pays : United States

Auteurs

A N Gupte (AN)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

S Selvaraju (S)

National Institute for Research in Tuberculosis, Chennai.

M Paradkar (M)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

K Danasekaran (K)

National Institute for Research in Tuberculosis, Chennai.

S V B Y Shivakumar (SVBY)

Johns Hopkins University India Office, Pune.

K Thiruvengadam (K)

National Institute for Research in Tuberculosis, Chennai.

C Dolla (C)

National Institute for Research in Tuberculosis, Chennai.

G Shivaramakrishnan (G)

National Institute for Research in Tuberculosis, Chennai.

N Pradhan (N)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

R Kohli (R)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

S John (S)

National Institute for Research in Tuberculosis, Chennai.

S Raskar (S)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

D Jain (D)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

A Momin (A)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

B Subramanian (B)

National Institute for Research in Tuberculosis, Chennai.

A Gaikwad (A)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

R Lokhande (R)

Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune.

N Suryavanshi (N)

Byramjee Jeejeebhoy Government Medical College-Johns Hopkins University Clinical Research Site, Pune.

N Gupte (N)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

S Salvi (S)

Chest Research Foundation, Pune, India.

L Murali (L)

National Institute for Research in Tuberculosis, Chennai.

W Checkley (W)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

J E Golub (JE)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

R Bollinger (R)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

P Chandrasekaran (P)

National Institute for Research in Tuberculosis, Chennai.

V Mave (V)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

A Gupta (A)

Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH